clinical trial · NCT07519109
Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.
CSPC Ouyi Pharmaceutical Co., Ltd.·phase1·not yet recruiting·n = 60
Postoperative PainSYH9089 injectionRopivacaine hydrochloride0.9 % sodium chloride
brief summary
This is a randomized, double-blind, active drug- and placebo-controlled, dose-escalation clinical study conducted in patients scheduled to undergo abdominal surgery. It aims to evaluate the tolerability, safety, pharmacokinetics, and efficacy of SYH9089 Injection for postoperative analgesia in these patients.
started
Mar 31, 2026
primary completion
Dec 31, 2026
completion
Mar 31, 2027
last updated
Apr 9, 2026
official title
A Multicenter, Randomized, Double-Blind, Active Drug and Placebo Parallel-Controlled, Dose-Escalation Phase I Study to Evaluate the Safety , Pharmacokinetics, and Efficacy of SYH9089 Injection in Patients Undergoing Abdominal Surgery
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol